Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
ID: ALA3797890
Max Phase: Preclinical
Molecular Formula: C28H33N3O2
Molecular Weight: 443.59
Molecule Type: Small molecule
Associated Items:
ID: ALA3797890
Max Phase: Preclinical
Molecular Formula: C28H33N3O2
Molecular Weight: 443.59
Molecule Type: Small molecule
Associated Items:
Canonical SMILES: Cc1cccc(C)c1NC(=O)C(C1CCCCC1)N1CCc2c([nH]c3ccccc23)CC1=O
Standard InChI: InChI=1S/C28H33N3O2/c1-18-9-8-10-19(2)26(18)30-28(33)27(20-11-4-3-5-12-20)31-16-15-22-21-13-6-7-14-23(21)29-24(22)17-25(31)32/h6-10,13-14,20,27,29H,3-5,11-12,15-17H2,1-2H3,(H,30,33)
Standard InChI Key: DFYAZARZVNKUBL-UHFFFAOYSA-N
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Small molecule | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Molecular Weight: 443.59 | Molecular Weight (Monoisotopic): 443.2573 | AlogP: 5.30 | #Rotatable Bonds: 4 |
Polar Surface Area: 65.20 | Molecular Species: NEUTRAL | HBA: 2 | HBD: 2 |
#RO5 Violations: 1 | HBA (Lipinski): 5 | HBD (Lipinski): 2 | #RO5 Violations (Lipinski): 1 |
CX Acidic pKa: 13.59 | CX Basic pKa: | CX LogP: 5.58 | CX LogD: 5.58 |
Aromatic Rings: 3 | Heavy Atoms: 33 | QED Weighted: 0.57 | Np Likeness Score: -0.49 |
1. Rentería-Gómez A, Islas-Jácome A, Díaz-Cervantes E, Villaseñor-Granados T, Robles J, Gámez-Montaño R.. (2016) Synthesis of azepino[4,5-b]indol-4-ones via MCR/free radical cyclization and in vitro-in silico studies as 5-Ht₆R ligands., 26 (9): [PMID:26996373] [10.1016/j.bmcl.2016.03.036] |
Source(1):